Top FDA gene and cell therapy regulator to step down

Following Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.

Following Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.

Steve Walsh, the CEO of a Massachusetts hospital group, will assume the top role in the early fall, after the AHA’s longtime leader retires.

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

Twenty-six states are seeking to overturn some of the regulation released by the CMS this month that outlined Medicaid work requirements — and asking the court to pause implementation for the time being.

The health IT regulator awarded a new contract to oversee the framework’s rules for data sharing as the number of health records exchanged through TEFCA balloons.
The system said a longer transition before Dr. Omar Lateef’s departure will ensure stability as it searches for a new leader.

ACA plan enrollment continues to shrink following the lapse of more generous subsidies last year, according to new federal data.
AI in healthcare is here. Learn how Dragon Copilot equips 100,000+ clinicians with tools that improve outcomes and streamline workflows.
How aligning on provider-level quality measurement becomes healthcare’s best cost lever.

The Trump administration says its war on fraud applies to the entire country. But only blue states have had their Medicaid funding threatened or deferred, Democrats argued in a House subcommittee hearing Thursday.